<DOC>
	<DOCNO>NCT01151930</DOCNO>
	<brief_summary>The primary objective characterize safety profile long-term exposure SCB01A administer cancer subject advance solid tumor . Furthermore , efficacy profile also explore study .</brief_summary>
	<brief_title>Long-Term Compassionate Use Study Continued Administration SCB01A-01</brief_title>
	<detailed_description>This companion study protocol SCB01A-01 intend provide long-term continued administration subject complete Protocol SCB01A-01 compassionate basis . It open-label , single-arm study SCB01A subject complete least one cycle treatment SCB01A-01 protocol .</detailed_description>
	<criteria>Subjects complete protocol SCB01A01 exhibit favorable response clinical evidence disease progression ( i.e . stable disease , partial response complete response ) . Study participant meet follow criterion exclude enrollment : 1 . Unwilling unable provide inform consent . 2 . Unwilling unable comply requirement protocol . 3 . Has unresolved toxicity previous SCB01A01 protocol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Advanced solid tumor fail standard therapy</keyword>
</DOC>